CARMIEL, Israel, Sept. 7 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX) today announced the appointment of Mr. Tzvi Palash as the Company's Chief Operating Officer. In this newly created position, Mr. Palash will be responsible for overseeing the Company's manufactur